Entera Bio Ltd.
- ENTX
- NASDAQ
- Biotechnology
- Oral Biologics
- Clinical-stage Biotech
- Large Molecule Delivery
$2.68
Today −3.25%Quote Oct 16, 2026, 08:00 PM UTC
−11.55%over the last month
Max drawdown −17.8%From 1-month high −11.6%3 months +34.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$465.9M
Quote Oct 16
Next earnings
Nov 13
Expected, not confirmed
Analyst target
$9.00
+235.8% from here
Floor
$2.67
0.5% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ENTXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
21